Diabetic emergencies-ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia

Nature Reviews Endocrinology

Volumn 12, Issue 4, 2016, Pages 222-232

  Umpierrez, Guillermo ^a   Korytkowski, Mary ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CARBOHYDRATE; GLUCAGON; GLUCOSE; INFUSION FLUID; INSULIN; OCTREOTIDE; PHOSPHATE; POTASSIUM; ANTIDIABETIC AGENT;

CARBOHYDRATE METABOLISM; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; DISEASE DURATION; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FLUID THERAPY; GLOMERULUS FILTRATION RATE; GLUCONEOGENESIS; GLUCOSE INTAKE; GLYCEMIC CONTROL; GROUPS BY AGE; HUMAN; HYPERGLYCEMIA; HYPERGLYCEMIC HYPEROSMOLAR STATE; HYPEROSMOLARITY; HYPOGLYCEMIA; INSULIN DEFICIENCY; INSULIN SENSITIVITY; INSULIN TREATMENT; KETOGENESIS; KIDNEY FAILURE; KIDNEY TUBULE ABSORPTION; LIVER FAILURE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSESTERIFICATION; CHEMICALLY INDUCED; COMPLICATION; DEHYDRATION; EMERGENCY; HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROCEDURES;

DEHYDRATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; EMERGENCIES; FLUID THERAPY; HUMANS; HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 84961217748     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2016.15     Document Type: Review

References (123)

1. Kitabchi, A. E., Umpierrez, G. E., Miles, J. M. & Fisher, J. N. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 32, 1335-1343 (2009
2. Centers for Disease Control and Prevention. Diabetes data & trends. [online], http: //www.cdc.gov/nchs/fastats/ inpatient-surgery.htm (2015
3. Fishbein, H. A. & Palumbo, P. J. in Diabetes in America 2nd edn Ch. 13 283-291 (National Institutes of Health, 1995
4. Pasquel, F. J. & Umpierrez, G. E. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 37, 3124-3131 (2014
5. Geller, A. I., et al. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. JAMA Int. Med. 174, 678-686 (2014
6. Krikorian, A., Ismail-Beigi, F. & Moghissi, E. S. Comparisons of different insulin infusion protocols: a review of recent literature. Curr. Opin. Clin. Nutr. Metab. Care 13, 198-204 (2010
7. Umpierrez, G. E., et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care 30, 2181-2186 (2007
8. Umpierrez, E., et al. Randomized study of basal bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care 34, 256-261 (2011
9. Basu, A., et al. Persisting mortality in diabetic ketoacidosis. Diabet. Med. 10, 282-284 (1993
10. Malone, M. L., Gennis, V. & Goodwin, J. S. Characteristics of diabetic ketoacidosis in older versus younger adults. J. Am. Geriatr. Soc. 40, 1100-1104 (1992
11. Bhowmick, S. K., Levens, K. L. & Rettig, K. R. Hyperosmolar hyperglycemic crisis: an acute life-threatening event in children and adolescents with type 2 diabetes mellitus. Endocr. Pract. 11, 23-29 (2005
12. Fadini, G. P., et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res. Clin. Pract. 94, 172-179 (2011
13. McCoy, R. G., et al. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care 35, 1897-1901 (2012
14. Kitabchi, A. E., et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24, 131-153 (2001
15. Umpierrez, G. E., Kelly, J. P., Navarrete, J. E., Casals, M. M. & Kitabchi, A. E. Hyperglycemic crises in urban blacks. Arch. Intern. Med. 157, 669-675 (1997
16. Boucai, L., Southern, W. N. & Zonszein, J. Hypoglycemia-Associated mortality is not drug-Associated but linked to comorbidities. Am. J. Med. 124, 1028-1035 (2011
17. Kosiborod, M., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301, 1556-1564 (2009
18. Garg, R., Hurwitz, S., Turchin, A. & Trivedi, A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care 36, 1107-1110 (2013
19. Finfer, S., et al. Hypoglycemia and risk of death in critically ill patients. N. Engl. J. Med. 367, 1108-1118 (2012
20. Carey, M., Boucai, L. & Zonszein, J. Impact of hypoglycemia in hospitalized patients. Curr. Diabetes Rep. 13, 107-113 (2013
21. Rhoads, G. G., et al. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J. Occup. Environ. Med. 47, 447-452 (2005
22. Turchin, A., et al. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care 32, 1153-1157 (2009
23. Randall, L., et al. Recurrent diabetic ketoacidosis in inner-city minority patients: behavioral, socioeconomic, and psychosocial factors. Diabetes Care 34, 1891-1896 (2011
24. Taylor, S. I., Blau, J. E. & Rother, K. I. SGLT2 inhibitors may predispose to ketoacidosis. J. Clin. Endocrinol. Metab. 100, 2849-2852 (2015
25. Peters, A. L., et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 38, 1687-1693 (2015
26. Ennis, E. D., Stahl, E. J. & Kreisberg, R. A. The hyperosmolar hyperglycemic syndrome. Diabetes Rev. 2, 115-126 (1994
27. Foster, D. W. & McGarry, J. D. The metabolic derangements and treatment of diabetic ketoacidosis. N. Engl. J. Med. 309, 159-169 (1983
28. McGarry, J. D. & Foster, D. W. Regulation of hepatic fatty acid oxidation and ketone body production. Ann. Rev. Biochem. 49, 395-420 (1980
29. McGarry, J. D., Woeltje, K. F., Kuwajima, M. & Foster, D. W. Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase. Diabetes Metab. Rev. 5, 271-284 (1989
30. Reichard, G. A. Jr, Skutches, C. L., Hoeldtke, R. D. & Owen, O. E. Acetone metabolism in humans during diabetic ketoacidosis. Diabetes 35, 668-674 (1986
31. Gerich, J. E., Martin, M. M. & Recant, L. Clinical and metabolic characteristics of hyperosmolar nonketotic coma. Diabetes 20, 228-238 (1971
32. Umpierrez, G. & Freire, A. X. Abdominal pain in patients with hyperglycemic crises. J. Crit. Care 17, 63-67 (2002
33. Guo, R. X., Yang, L. Z., Li, L. X. & Zhao, X. P. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J. Obstet. Gynaecol. Res. 34, 324-330 (2008
34. Stephens, J. M., Sulway, M. J. & Watkins, P. J. Relationship of blood acetoacetate and 3 hydroxybutyrate in diabetes. Diabetes 20, 485-489 (1971
35. Sheikh-Ali, M., et al. Can serum β hydroxybutyrate be used to diagnose diabetic ketoacidosis?. Diabetes Care 31, 643-647 (2008
36. Taboulet, P., et al. Urinary acetoacetate or capillary β hydroxybutyrate for the diagnosis of ketoacidosis in the emergency department setting. Eur. J. Emerg. Med. 11, 251-258 (2004
37. Arieff, A. I. & Kleeman, C. R. Cerebral edema in diabetic comas. II. Effects of hyperosmolality, hyperglycemia and insulin in diabetic rabbits. J. Clin. Endocrinol. Metab. 38, 1057-1067 (1974
38. Luzi, L., Barrett, E. J., Groop, L. C., Ferrannini, E. & DeFronzo, R. A. Metabolic effects of low-dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes 37, 1470-1477 (1988
39. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Hyperglycemic emergencies in adults. Can. J. Diabetes 37, S72-S76 (2013
40. Goyal, N., Miller, J. B., Sankey, S. S. & Mossallam, U. Utility of initial bolus insulin in the treatment of diabetic ketoacidosis. J. Emerg. Med. 38, 422-427 (2010
41. Kitabchi, A. E., Ayyagari, V. & Guerra, S. M. The efficacy of low-dose versus conventional therapy of insulin for treatment of diabetic ketoacidosis. Ann. Intern. Med. 84, 633-638 (1976
42. Umpierrez, G. E., et al. Insulin analogs versus human insulin in the treatment of patients with diabetic ketoacidosis: a randomized controlled trial. Diabetes Care 32, 1164-1169 (2009
43. Umpierrez, G. E., et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am. J. Med. 117, 291-296 (2004
44. Ersoz, H. O., et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int. J. Clin. Pract. 60, 429-433 (2006
45. Karoli, R., Fatima, J., Salman, T., Sandhu, S. & Shankar, R. Managing diabetic ketoacidosis in non-intensive care unit setting: role of insulin analogs. Indian J. Pharmacol. 43, 398-401 (2011
46. Umpierrez, G. E., et al. Subcutanbeous aspart insulin: a safe and cost effective treatment of diabetic ketoacidosis. Diabetes 52 (Suppl. 1), 584A (2003
47. Sobngwi, E., et al. Evaluation of a simple management protocol for hyperglycaemic crises using intramuscular insulin in a resource-limited setting. Diabetes Metab. 35, 404-409 (2009
48. Adrogue, H. J., Lederer, E. D., Suki, W. N. & Eknoyan, G. Determinants of plasma potassium levels in diabetic ketoacidosis. Med. (Baltimore) 65, 163-172 (1986
49. Chua, H. R., Schneider, A. & Bellomo, R. Bicarbonate in diabetic ketoacidosis - a systematic review. Ann. Intensive Care 1, 23 (2011
50. Fisher, J. N. & Kitabchi, A. E. A randomized study of phosphate therapy in the treatment of diabetic ketoacidosis. J. Clin. Endocrinol. Metab. 57, 177-180 (1983
51. Wilson, H. K., Keuer, S. P., Lea, A. S. & Boyd, A. E. 3rd & Eknoyan, G. Phosphate therapy in diabetic ketoacidosis. Arch. Intern. Med. 142, 517-520 (1982
52. Winter, R. J., Harris, C. J., Phillips, L. S. & Green, O. C. Diabetic ketoacidosis: induction of hypocalcemia and hypomagnesemia by phosphate therapy. Am. J. Med. 67, 897-900 (1979
53. White, N. H. Diabetic ketoacidosis in children. Endocrinol. Metab. Clin. North Am. 29, 657-682 (2000
54. Savage, M. W., et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabet. Med. 28, 508-515 (2011
55. Hsia, E., et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J. Clin. Endocrinol. Metab. 97, 3132-3137 (2012
56. Jefferies, C. A., et al. Preventing diabetic ketoacidosis. Pediatr. Clin. North Am. 62, 857-871 (2012
57. Vanelli, M., et al. Effectiveness of a prevention program for diabetic ketoacidosis in children. An 8 year study in schools and private practices. Diabetes Care 22, 7-9 (1999
58. Laffel, L. Sick-day management in type 1 diabetes. Endocrinol. Metab. Clin. North Am. 29, 707-723 (2000
59. U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood. [online], http: //www.fda.gov/Drugs/ DrugSafety/ucm446845.htm (2015
60. European Medicines Agency. Review of diabetes medicines called SGLT2 inhibitors started. Risk of diabetic ketoacidosis to be examined. [online], http: // www.ema.europa.eu/docs/en-GB/document-library/ Referrals-document/SGLT2-inhibitors-20/Procedure- started/WC500187926.pdf (2015
61. Erondu, N., Desai, M., Ways, K. & Meininger, G. Diabetic ketoacidosis and related events in the canagliflozin type 2 diabetes clinical program. Diabetes Care 38, 1680-1686 (2015
62. Cryer, P. E. Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63, 2188-2195 (2014
63. Cryer, P. Hypoglycemia during therapy of diabetes. Endotext.org [online], http: //www.endotext.org/ (2015
64. Cryer, P. E. Hypoglycemia-Associated autonomic failure in diabetes: maladaptive, adaptive, or both?. Diabetes 64, 2322-2323 (2015
65. Weinstock, R. S., et al. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J. Clin. Endocrinol. Metab. 98, 3411-3419 (2013
66. Miller, C. D., et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch. Intern. Med. 161, 1653-1659 (2001
67. McCoy, R. G., et al. Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes. Endocr. Pract. 19, 792-799 (2013
68. Wexler, D. J., Meigs, J. B., Cagliero, E., Nathan, D. M. & Grant, R. W. Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals. Diabetes Care 30, 367-369 (2007
69. Umpierrez, G. E., et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care 36, 2169-2174 (2013
70. Lleva, R. R., Thomas, P., Bozzo, J. E., Hendrickson, K. C. & Inzucchi, S. E. Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study. J. Diabetes Sci. Technol. 8, 918-922 (2014
71. Leese, G. P., et al. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care 26, 1176-1180 (2003
72. Kerry, C., Mitchell, S., Sharma, S., Scott, A. & Rayman, G. Diurnal temporal patterns of hypoglycaemia in hospitalized people with diabetes may reveal potentially correctable factors. Diabet. Med. 30, 1403-1406 (2013
73. Seaquist, E. R., et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J. Clin. Endocrinol. Metab. 98, 1845-1859 (2013
74. Seaquist, E. R., et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care 36, 1384-1395 (2013
75. Cryer, P. E., Davis, S. N. & Shamoon, H. Hypoglycemia in diabetes. Diabetes Care 26, 1902-1912 (2003
76. Moghissi, E. S., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr. Pract. 15, 353-369 (2009
77. Moghissi, E. S., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32, 1119-1131 (2009
78. Umpierrez, G. E., et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 97, 16-38 (2012
79. Hsu, P. F., et al. Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study. Diabetes Care 36, 894-900 (2013
80. Chow, E., et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63, 1738-1747 (2014
81. Goto, A., Arah, O. A., Goto, M., Terauchi, Y. & Noda, M. Severe hypoglycaemia and cardiovascular disease: systematic review and meta-Analysis with bias analysis. BMJ 347, f4533 (2013
82. Reno, C. M., et al. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes 62, 3570-3581 (2013
83. Tsujimoto, T., et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care 37, 217-225 (2014
84. Tanenberg, R. J., Newton, C. A. & Drake, A. J. Confirmation of hypoglycemia in the 'dead in bed' syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr. Pract. 16, 244-248 (2010
85. Razavi Nematollahi, L., et al. Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 58, 443-448 (2009
86. Seaquist, E. R., et al. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care 35, 409-414 (2012
87. The Accord Study Group. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med. 364, 818-828 (2011
88. Miller, M. E., et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340, b5444 (2010
89. Boussageon, R., et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-Analysis of randomised controlled trials. BMJ 343, d4169 (2011
90. Zoungas, S., et al. Severe hypoglycemia and risks of vascular events and death. N. Engl. J. Med. 363, 1410-1418 (2010
91. Fox, C. S., et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 38, 1777-1803 (2015
92. Gill, G. V., Woodward, A., Casson, I. F. & Weston, P. J. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes - the 'dead in bed' syndrome revisited. Diabetologia 52, 42-45 (2009
93. Desouza, C. V., Bolli, G. B. & Fonseca, V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 33, 1389-1394 (2010
94. Amiel, S. A., Dixon, T., Mann, R. & Jameson, K. Hypoglycaemia in type 2 diabetes. Diabet. Med. 25, 245-254 (2008
95. Feinkohl, I., et al. Severe hypoglycemia and cognitive decline in older people with type 2 diabetes: the Edinburgh type 2 diabetes study. Diabetes Care 37, 507-515 (2014
96. DiNardo, M., Noschese, M., Korytkowski, M. & Freeman, S. The medical emergency team and rapid response system: finding, treating, and preventing hypoglycemia. Jt. Comm. J. Qual. Patient Saf. 32, 591-595 (2006
97. Korytkowski, M., DiNardo, M., Donihi, A. C., Bigi, L. & Devita, M. Evolution of a diabetes inpatient safety committee. Endocr. Pract. 12 (Suppl. 3), 91-99 (2006
98. Umpierrez, G. E., et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 97, 16-38 (2012
99. Maynard, G., Lee, J., Phillips, G., Fink, E. & Renvall, M. Improved inpatient use of basal insulin, reduced hypoglycemia, and improved glycemic control: effect of structured subcutaneous insulin orders and an insulin management algorithm. J. Hosp. Med. 4, 3-15 (2009
100. Noschese, M., et al. Effect of a diabetes order set on glycaemic management and control in the hospital. Qual. Saf. Health Care 17, 464-468 (2008
101. Korytkowski, M., McDonnell, M. E., Umpierrez, G. E. & Zonszein, J. Patient guide to managing hyperglycemia (high blood sugar) in the hospital. J. Clin. Endocrinol. Metab. 97, 27A-28A (2012
102. Moore, C. & Woollard, M. Dextrose 10% or 50% in the treatment of hypoglycaemia out of hospital?. A randomised controlled trial. Emerg. Med. J. 22, 512-515 (2005
103. Graveling, A. J. & Frier, B. M. Risks of marathon running and hypoglycaemia in type 1 diabetes. Diabet. Med. 27, 585-588 (2010
104. Schabelman, E. & Kuo, D. Glucose before thiamine for Wernicke encephalopathy: a literature review. J. Emerg. Med. 42, 488-494 (2012
105. Deusenberry, C. M., Coley, K. C., Korytkowski, M. T. & Donihi, A. C. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy 32, 613-617 (2012
106. Fleseriu, M., Skugor, M., Chinnappa, P. & Siraj, E. S. Successful treatment of sulfonylurea-induced prolonged hypoglycemia with use of octreotide. Endocr. Pract. 12, 635-640 (2006
107. Korytkowski, M. T. Diabetes and aging. Diabetes Spectrum. 26, 3-4 (2013
108. Little, S. A., et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 - 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 37, 2114-2122 (2014
109. Samann, A., Muhlhauser, I., Bender, R., Kloos, C. & Muller, U. A. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 48, 1965-1970 (2005
110. Bott, S., Bott, U., Berger, M. & Muhlhauser, I. Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia 40, 926-932 (1997
111. Yeoh, E., Choudhary, P., Nwokolo, M., Ayis, S. & Amiel, S. A. Interventions that restore awareness of hypoglycemia in adults with type 1 diabetes: a systematic review and meta-Analysis. Diabetes Care 38, 1592-1609 (2015
112. Tylee, T. & Hirsch, I. B. Costs associated with using different insulin preparations. JAMA 314, 665-666 (2015
113. Bergenstal, R. M., Welsh, J. B. & Shin, J. J. Threshold insulin-pump interruption to reduce hypoglycemia. N. Engl. J. Med. 369, 1474 (2013
114. Baldwin, D., et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care 35, 1970-1974 (2012
115. Thuzar, M., Malabu, U. H., Tisdell, B. & Sangla, K. S. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res. Clin. Pract. 104, e8-e11 (2014
116. Weinert, L. S., et al. Precipitating factors of diabetic ketoacidosis at a public hospital in a middle-income country. Diabetes Res. Clin. Pract. 96, 29-34 (2012
117. Tan, H., Zhou, Y. & Yu, Y. Characteristics of diabetic ketoacidosis in Chinese adults and adolescents - a teaching hospital-based analysis. Diabetes Res. Clin. Pract. 97, 306-312 (2012
118. Suwarto, S., Sutrisna, B., Waspadji, S. & Pohan, H. T. Predictors of five days mortality in diabetic ketoacidosis patients: a prospective cohort study. Acta Med. Indones. 46, 18-23 (2014
119. Ko, S. H., et al. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades. Diabet. Med. 22, 466-469 (2005
120. Edo, A. E. Clinical profile and outcomes of adult patients with hyperglycemic emergencies managed at a tertiary care hospital in Nigeria. Niger. Med. J. 53, 121-125 (2012
121. Guisado-Vasco, P., et al. Clinical features, mortality, hospital admission, and length of stay of a cohort of adult patients with diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain. Endocrinol. Nutr. 62, 277-284 (2015).
122. Alourfi, Z. & Homsi, H. Precipitating factors, outcomes, and recurrence of diabetic ketoacidosis at a university hospital in Damascus. Avicenna J. Med. 5, 11-15 (2015
123. Lin, S. F., Lin, J. D. & Huang, Y. Y. Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med. J. 28, 24-30 (2005